Global Complement C5 Recombinant Monoclonal Antibody Market Growth 2026-2032

January 2026 | 83 pages | ID: G5DC13E6AEACEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Complement C5 Recombinant Monoclonal Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Complement C5 recombinant monoclonal antibody is a biologic drug designed to specifically target and block complement protein C5, which is a critical component of the immune system?s complement pathway.This class of drugs is used to treat diseases caused by excessive complement activation, such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica spectrum disorder (NMOSD).

United States market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Complement C5 Recombinant Monoclonal Antibody is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Complement C5 Recombinant Monoclonal Antibody players cover Regeneron Pharmaceuticals, Alexion Pharmaceuticals, Amgen, Samsung Bioepis, Roche, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the ?Complement C5 Recombinant Monoclonal Antibody Industry Forecast? looks at past sales and reviews total world Complement C5 Recombinant Monoclonal Antibody sales in 2025, providing a comprehensive analysis by region and market sector of projected Complement C5 Recombinant Monoclonal Antibody sales for 2026 through 2032. With Complement C5 Recombinant Monoclonal Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Complement C5 Recombinant Monoclonal Antibody industry.

This Insight Report provides a comprehensive analysis of the global Complement C5 Recombinant Monoclonal Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Complement C5 Recombinant Monoclonal Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Complement C5 Recombinant Monoclonal Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Complement C5 Recombinant Monoclonal Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Complement C5 Recombinant Monoclonal Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Complement C5 Recombinant Monoclonal Antibody market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Crovalimab
  • Ravulizumab
  • Eculizumab
  • Pozelimab
  • Others
Segmentation by Application:
  • PNH
  • aHUS
  • CD55 Deficiency
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Regeneron Pharmaceuticals
  • Alexion Pharmaceuticals
  • Amgen
  • Samsung Bioepis
  • Roche
Key Questions Addressed in this Report
What is the 10-year outlook for the global Complement C5 Recombinant Monoclonal Antibody market?
What factors are driving Complement C5 Recombinant Monoclonal Antibody market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Complement C5 Recombinant Monoclonal Antibody market opportunities vary by end market size?
How does Complement C5 Recombinant Monoclonal Antibody break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Complement C5 Recombinant Monoclonal Antibody Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Complement C5 Recombinant Monoclonal Antibody by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Complement C5 Recombinant Monoclonal Antibody by Country/Region, 2021, 2025 & 2032
2.2 Complement C5 Recombinant Monoclonal Antibody Segment by Type
  2.2.1 Crovalimab
  2.2.2 Ravulizumab
  2.2.3 Eculizumab
  2.2.4 Pozelimab
  2.2.5 Others
  2.2.6 Complement C5 Recombinant Monoclonal Antibody Sales by Type
    2.2.6.1 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
    2.2.6.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue and Market Share by Type (2021-2026)
    2.2.6.3 Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Type (2021-2026)
2.3 Complement C5 Recombinant Monoclonal Antibody Segment by Application
  2.3.1 PNH
  2.3.2 aHUS
  2.3.3 CD55 Deficiency
  2.3.4 Others
  2.3.5 Complement C5 Recombinant Monoclonal Antibody Sales by Application
    2.3.5.1 Global Complement C5 Recombinant Monoclonal Antibody Sale Market Share by Application (2021-2026)
    2.3.5.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue and Market Share by Application (2021-2026)
    2.3.5.3 Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Complement C5 Recombinant Monoclonal Antibody Breakdown Data by Company
  3.1.1 Global Complement C5 Recombinant Monoclonal Antibody Annual Sales by Company (2021-2026)
  3.1.2 Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Company (2021-2026)
3.2 Global Complement C5 Recombinant Monoclonal Antibody Annual Revenue by Company (2021-2026)
  3.2.1 Global Complement C5 Recombinant Monoclonal Antibody Revenue by Company (2021-2026)
  3.2.2 Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Company (2021-2026)
3.3 Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Company
3.4 Key Manufacturers Complement C5 Recombinant Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Complement C5 Recombinant Monoclonal Antibody Product Location Distribution
  3.4.2 Players Complement C5 Recombinant Monoclonal Antibody Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR COMPLEMENT C5 RECOMBINANT MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION

4.1 World Historic Complement C5 Recombinant Monoclonal Antibody Market Size by Geographic Region (2021-2026)
  4.1.1 Global Complement C5 Recombinant Monoclonal Antibody Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Complement C5 Recombinant Monoclonal Antibody Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Complement C5 Recombinant Monoclonal Antibody Market Size by Country/Region (2021-2026)
  4.2.1 Global Complement C5 Recombinant Monoclonal Antibody Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Complement C5 Recombinant Monoclonal Antibody Annual Revenue by Country/Region (2021-2026)
4.3 Americas Complement C5 Recombinant Monoclonal Antibody Sales Growth
4.4 APAC Complement C5 Recombinant Monoclonal Antibody Sales Growth
4.5 Europe Complement C5 Recombinant Monoclonal Antibody Sales Growth
4.6 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Growth

5 AMERICAS

5.1 Americas Complement C5 Recombinant Monoclonal Antibody Sales by Country
  5.1.1 Americas Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  5.1.2 Americas Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021-2026)
5.2 Americas Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026)
5.3 Americas Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Complement C5 Recombinant Monoclonal Antibody Sales by Region
  6.1.1 APAC Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026)
  6.1.2 APAC Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026)
6.2 APAC Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026)
6.3 APAC Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Complement C5 Recombinant Monoclonal Antibody by Country
  7.1.1 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  7.1.2 Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021-2026)
7.2 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026)
7.3 Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody by Country
  8.1.1 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021-2026)
8.2 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026)
8.3 Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Complement C5 Recombinant Monoclonal Antibody
10.3 Manufacturing Process Analysis of Complement C5 Recombinant Monoclonal Antibody
10.4 Industry Chain Structure of Complement C5 Recombinant Monoclonal Antibody

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Complement C5 Recombinant Monoclonal Antibody Distributors
11.3 Complement C5 Recombinant Monoclonal Antibody Customer

12 WORLD FORECAST REVIEW FOR COMPLEMENT C5 RECOMBINANT MONOCLONAL ANTIBODY BY GEOGRAPHIC REGION

12.1 Global Complement C5 Recombinant Monoclonal Antibody Market Size Forecast by Region
  12.1.1 Global Complement C5 Recombinant Monoclonal Antibody Forecast by Region (2027-2032)
  12.1.2 Global Complement C5 Recombinant Monoclonal Antibody Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Complement C5 Recombinant Monoclonal Antibody Forecast by Type (2027-2032)
12.7 Global Complement C5 Recombinant Monoclonal Antibody Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Regeneron Pharmaceuticals
  13.1.1 Regeneron Pharmaceuticals Company Information
  13.1.2 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
  13.1.3 Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Regeneron Pharmaceuticals Main Business Overview
  13.1.5 Regeneron Pharmaceuticals Latest Developments
13.2 Alexion Pharmaceuticals
  13.2.1 Alexion Pharmaceuticals Company Information
  13.2.2 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
  13.2.3 Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Alexion Pharmaceuticals Main Business Overview
  13.2.5 Alexion Pharmaceuticals Latest Developments
13.3 Amgen
  13.3.1 Amgen Company Information
  13.3.2 Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
  13.3.3 Amgen Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Amgen Main Business Overview
  13.3.5 Amgen Latest Developments
13.4 Samsung Bioepis
  13.4.1 Samsung Bioepis Company Information
  13.4.2 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
  13.4.3 Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Samsung Bioepis Main Business Overview
  13.4.5 Samsung Bioepis Latest Developments
13.5 Roche
  13.5.1 Roche Company Information
  13.5.2 Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
  13.5.3 Roche Complement C5 Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Roche Main Business Overview
  13.5.5 Roche Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES

Table 1. Complement C5 Recombinant Monoclonal Antibody Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Complement C5 Recombinant Monoclonal Antibody Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Crovalimab
Table 4. Major Players of Ravulizumab
Table 5. Major Players of Eculizumab
Table 6. Major Players of Pozelimab
Table 7. Major Players of Others
Table 8. Global Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units)
Table 9. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
Table 10. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Type (2021-2026) & ($ million)
Table 11. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2026)
Table 12. Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Complement C5 Recombinant Monoclonal Antibody Sale by Application (2021-2026) & (K Units)
Table 14. Global Complement C5 Recombinant Monoclonal Antibody Sale Market Share by Application (2021-2026)
Table 15. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Application (2021-2026) & ($ million)
Table 16. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application (2021-2026)
Table 17. Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Complement C5 Recombinant Monoclonal Antibody Sales by Company (2021-2026) & (K Units)
Table 19. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Company (2021-2026)
Table 20. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Company (2021-2026)
Table 22. Global Complement C5 Recombinant Monoclonal Antibody Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Complement C5 Recombinant Monoclonal Antibody Producing Area Distribution and Sales Area
Table 24. Players Complement C5 Recombinant Monoclonal Antibody Products Offered
Table 25. Complement C5 Recombinant Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Complement C5 Recombinant Monoclonal Antibody Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share Geographic Region (2021-2026)
Table 30. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Complement C5 Recombinant Monoclonal Antibody Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country/Region (2021-2026)
Table 34. Global Complement C5 Recombinant Monoclonal Antibody Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units)
Table 37. Americas Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026)
Table 38. Americas Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units)
Table 40. Americas Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units)
Table 41. APAC Complement C5 Recombinant Monoclonal Antibody Sales by Region (2021-2026) & (K Units)
Table 42. APAC Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region (2021-2026)
Table 43. APAC Complement C5 Recombinant Monoclonal Antibody Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units)
Table 45. APAC Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units)
Table 46. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units)
Table 47. Europe Complement C5 Recombinant Monoclonal Antibody Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units)
Table 49. Europe Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Complement C5 Recombinant Monoclonal Antibody
Table 55. Key Market Challenges & Risks of Complement C5 Recombinant Monoclonal Antibody
Table 56. Key Industry Trends of Complement C5 Recombinant Monoclonal Antibody
Table 57. Complement C5 Recombinant Monoclonal Antibody Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Complement C5 Recombinant Monoclonal Antibody Distributors List
Table 60. Complement C5 Recombinant Monoclonal Antibody Customer List
Table 61. Global Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Complement C5 Recombinant Monoclonal Antibody Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Complement C5 Recombinant Monoclonal Antibody Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Complement C5 Recombinant Monoclonal Antibody Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Complement C5 Recombinant Monoclonal Antibody Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Complement C5 Recombinant Monoclonal Antibody Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Complement C5 Recombinant Monoclonal Antibody Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. Regeneron Pharmaceuticals Basic Information, Complement C5 Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 76. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
Table 77. Regeneron Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Regeneron Pharmaceuticals Main Business
Table 79. Regeneron Pharmaceuticals Latest Developments
Table 80. Alexion Pharmaceuticals Basic Information, Complement C5 Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 81. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
Table 82. Alexion Pharmaceuticals Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Alexion Pharmaceuticals Main Business
Table 84. Alexion Pharmaceuticals Latest Developments
Table 85. Amgen Basic Information, Complement C5 Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 86. Amgen Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
Table 87. Amgen Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Amgen Main Business
Table 89. Amgen Latest Developments
Table 90. Samsung Bioepis Basic Information, Complement C5 Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 91. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
Table 92. Samsung Bioepis Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Samsung Bioepis Main Business
Table 94. Samsung Bioepis Latest Developments
Table 95. Roche Basic Information, Complement C5 Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Complement C5 Recombinant Monoclonal Antibody Product Portfolios and Specifications
Table 97. Roche Complement C5 Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Roche Main Business
Table 99. Roche Latest Developments

LIST OF FIGURES

Figure 1. Picture of Complement C5 Recombinant Monoclonal Antibody
Figure 2. Complement C5 Recombinant Monoclonal Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Complement C5 Recombinant Monoclonal Antibody Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Complement C5 Recombinant Monoclonal Antibody Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Complement C5 Recombinant Monoclonal Antibody Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country/Region (2025)
Figure 10. Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Crovalimab
Figure 12. Product Picture of Ravulizumab
Figure 13. Product Picture of Eculizumab
Figure 14. Product Picture of Pozelimab
Figure 15. Product Picture of Others
Figure 16. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type in 2026
Figure 17. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Type (2021-2026)
Figure 18. Complement C5 Recombinant Monoclonal Antibody Consumed in PNH
Figure 19. Global Complement C5 Recombinant Monoclonal Antibody Market: PNH (2021-2026) & (K Units)
Figure 20. Complement C5 Recombinant Monoclonal Antibody Consumed in aHUS
Figure 21. Global Complement C5 Recombinant Monoclonal Antibody Market: aHUS (2021-2026) & (K Units)
Figure 22. Complement C5 Recombinant Monoclonal Antibody Consumed in CD55 Deficiency
Figure 23. Global Complement C5 Recombinant Monoclonal Antibody Market: CD55 Deficiency (2021-2026) & (K Units)
Figure 24. Complement C5 Recombinant Monoclonal Antibody Consumed in Others
Figure 25. Global Complement C5 Recombinant Monoclonal Antibody Market: Others (2021-2026) & (K Units)
Figure 26. Global Complement C5 Recombinant Monoclonal Antibody Sale Market Share by Application (2025)
Figure 27. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Application in 2026
Figure 28. Complement C5 Recombinant Monoclonal Antibody Sales by Company in 2026 (K Units)
Figure 29. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Company in 2026
Figure 30. Complement C5 Recombinant Monoclonal Antibody Revenue by Company in 2026 ($ millions)
Figure 31. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Company in 2026
Figure 32. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Complement C5 Recombinant Monoclonal Antibody Sales 2021-2026 (K Units)
Figure 35. Americas Complement C5 Recombinant Monoclonal Antibody Revenue 2021-2026 ($ millions)
Figure 36. APAC Complement C5 Recombinant Monoclonal Antibody Sales 2021-2026 (K Units)
Figure 37. APAC Complement C5 Recombinant Monoclonal Antibody Revenue 2021-2026 ($ millions)
Figure 38. Europe Complement C5 Recombinant Monoclonal Antibody Sales 2021-2026 (K Units)
Figure 39. Europe Complement C5 Recombinant Monoclonal Antibody Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Revenue 2021-2026 ($ millions)
Figure 42. Americas Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country in 2026
Figure 43. Americas Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021-2026)
Figure 44. Americas Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
Figure 45. Americas Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026)
Figure 46. United States Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Region in 2026
Figure 51. APAC Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Region (2021-2026)
Figure 52. APAC Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
Figure 53. APAC Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026)
Figure 54. China Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 58. India Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country in 2026
Figure 62. Europe Complement C5 Recombinant Monoclonal Antibody Revenue Market Share by Country (2021-2026)
Figure 63. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
Figure 64. Europe Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026)
Figure 65. Germany Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 66. France Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Complement C5 Recombinant Monoclonal Antibody Sales Market Share by Application (2021-2026)
Figure 73. Egypt Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Complement C5 Recombinant Monoclonal Antibody Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Complement C5 Recombinant Monoclonal Antibody in 2026
Figure 79. Manufacturing Process Analysis of Complement C5 Recombinant Monoclonal Antibody
Figure 80. Industry Chain Structure of Complement C5 Recombinant Monoclonal Antibody
Figure 81. Channels of Distribution
Figure 82. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Forecast by Region (2027-2032)
Figure 83. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Complement C5 Recombinant Monoclonal Antibody Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Complement C5 Recombinant Monoclonal Antibody Revenue Market Share Forecast by Application (2027-2032)